The price of larotrectinib varies significantly depending on region, dosage, and medical insurance policies. In China, the price is typically between 30,000 and 40,000 RMB per box (30 tablets), but the exact price should be confirmed with the hospital or authorized pharmacy. This is a prescription drug; strict adherence to doctor's instructions and a professional medical evaluation are required before use.
Domestic and International Price Differences
Domestic Price: After larotrectinib was approved for marketing in China in 2022, the price per box was approximately 30,000 to 40,000 RMB (30 tablets, 100mg/tablet), with slight fluctuations depending on procurement channels and regional policies.
US Original Drug Price: Approximately US$32,000/month (based on standard dosage). Some patients can reduce costs through insurance or assistance programs.
Price Influencing Factors
Dosage and Treatment Duration: Patients need to adjust the dosage according to their weight and condition; long-term use results in higher costs.
Medical Insurance and Assistance: Currently, this drug is not covered by China's medical insurance, but the burden can be alleviated through charitable drug donation programs; some hospitals or pharmacies offer installment payment options.
Medication Instructions and Precautions
Larotrectinib is indicated for patients with solid tumors containing NTRK gene fusions. Indication must be confirmed through genetic testing before use.
Common side effects include fatigue and dizziness. Regular monitoring of liver function and blood tests is necessary. If severe reactions occur, immediate medical attention is required to adjust the treatment plan.
Purchase Channels and Safety
It is only recommended to purchase from hospitals or qualified pharmacies to avoid the risks associated with medications from unofficial channels.
Maintain communication with your attending physician during treatment. Do not increase or decrease the dosage or discontinue medication on your own.
If you are experiencing financial difficulties, it is recommended to contact your attending physician or the hospital's social work department to learn about assistance programs or alternative treatment options to ensure treatment safety and sustainability.
